Fermín Goytisolo
Corporate Officer/Principal at PANGAEA ONCOLOGY, S.A.
Profile
Fermín Goytisolo is currently the Director of Business Development & Licensing at Pangaea Oncology SA. Prior to this, he worked as a Biotechnology Manager at Najeti Capital SA, a Partner at Metas Biotech SL, and a Licensing Manager at Esteve Pharmaceuticals S.A.
Fermín Goytisolo active positions
Companies | Position | Start |
---|---|---|
PANGAEA ONCOLOGY, S.A. | Corporate Officer/Principal | - |
Former positions of Fermín Goytisolo
Companies | Position | End |
---|---|---|
Esteve Pharmaceuticals S.A.
Esteve Pharmaceuticals S.A. Pharmaceuticals: OtherHealth Technology Esteve Pharmaceuticals S.A. operates as a global pharmaceutical company. It provides Ophthalmology and other Pathologies therapies. The company is headquartered in Barcelona, Spain. | Corporate Officer/Principal | - |
Najeti Capital SA
Najeti Capital SA Investment ManagersFinance Najeti Capital SA, formerly Najeti Capital SCR SA, invests in technology-driven, expansion projects with proprietary technologies across Europe with a special focus on Spain. It focuses on the sectors of biotechnology, telecommunications, media & technology (TMT) and services. The investment size ranges from €4 million to €8 million. It provides financing for growth or expansion capital requirements. It prefers to co-invest with other investors. | Corporate Officer/Principal | - |
Metas Biotech SL | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
PANGAEA ONCOLOGY, S.A. | Health Technology |
Private companies | 3 |
---|---|
Najeti Capital SA
Najeti Capital SA Investment ManagersFinance Najeti Capital SA, formerly Najeti Capital SCR SA, invests in technology-driven, expansion projects with proprietary technologies across Europe with a special focus on Spain. It focuses on the sectors of biotechnology, telecommunications, media & technology (TMT) and services. The investment size ranges from €4 million to €8 million. It provides financing for growth or expansion capital requirements. It prefers to co-invest with other investors. | Finance |
Metas Biotech SL | |
Esteve Pharmaceuticals S.A.
Esteve Pharmaceuticals S.A. Pharmaceuticals: OtherHealth Technology Esteve Pharmaceuticals S.A. operates as a global pharmaceutical company. It provides Ophthalmology and other Pathologies therapies. The company is headquartered in Barcelona, Spain. | Health Technology |
- Stock Market
- Insiders
- Fermín Goytisolo